← Open Payments lookup

THOMAS GAZDA: Open Payments

NPI 1730158189 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$53,799 in 47 payments from 7 companies in 2025. Trend: 2023 $207,098 · 2024 $117,875 · 2025 $53,799

Speaker / faculty: $28,552Honoraria: $17,613Travel & lodging: $5,870Food & beverage: $1,763
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.26$27,153
Axsome Therapeutics, Inc.14$18,343
Teva Pharmaceuticals USA, Inc.3$5,833
Luye Pharma (USA) Ltd.1$1,750
Janssen Pharmaceuticals, Inc1$585
Braeburn Inc.1$110
Alkermes, Inc.1$25

Products named: COBENFY, Auvelity, UZEDY, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, BRIXADI, ARISTADA.

Industry payments across AZ — which companies pay providers there.